The fight against Alzheimer’s disease is gaining momentum, as evidenced by the surging Alzheimer Therapeutics Market.

A host of links on the newly updated website include Alzheimer’s and related dementias, life with dementia, clinical trials, ...

The amyloid hypothesis holds that sticky plaques and other so-called amyloid-beta proteins build up in the brain and prompt ...

T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative diagnostics and therapeutics for ...

“Our research highlights the potential of nasal tau immunotherapy to effectively target intracellular tau aggregates – a ...

The Food and Drug Administration (FDA) recently approved a new drug from Eli Lilly to treat Alzheimer’s disease. Called ...

The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV ...

Share on PinterestWill clinicians soon have a tool to predict different cognitive decline stages in Alzheimer’s disease?

Professor Uri Ashery is a prominent Israeli neuroscientist who heads the Learning and Memory Lab at Tel Aviv University’s ...

Researchers at the Terasaki Institute for Biomedical Innovation in Los Angeles have made a significant breakthrough in ...

Alzheimer’s disease is a common illness that affects many older people around the world, and it is one of the main causes of ...

Scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer's disease ...